Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and cont...
The Ministry of Science, Innovation and Universities announced this Friday the winners of the 2025 National Research Awards, one of the most presti...
An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research gr...
IDIBAPS is opening a call for up to 9 predoctoral fellowships in biomedicine, funded by the “Agencia Estatal de Investigación”. This proposal is ai...
A team led by Joan-Marc Servitja, from the IDIBAPS Pathogenesis and Prevention of Diabetes research group, has demonstrated in mouse models that hi...
Reducing aspirin to one month after a heart attack lowers bleeding risk without increasing cardiovascular complications.
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the...
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
